Mirae Asset Global ETFs Holdings’s Pacira BioSciences PCRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Sell	18,265 -923	-5%	-$21.8K	﹤0.01%	2051
2026 Q1	$434K	Sell	19,188 -1,555	-7%	-$34.6K	﹤0.01%	1954
2025 Q4	$537K	Sell	20,743 -641	-3%	-$15.2K	﹤0.01%	1855
2025 Q3	$551K	Sell	21,384 -3,842	-15%	-$94.4K	﹤0.01%	1824
2025 Q2	$603K	Sell	25,226 -2,016	-7%	-$50.8K	﹤0.01%	1720
2025 Q1	$677K	Buy	27,242 +1,165	+4%	+$27.9K	﹤0.01%	1698
2024 Q4	$491K	Buy	26,077 +794	+3%	+$13.9K	﹤0.01%	1931
2024 Q3	$381K	Buy	25,283 +2,505	+11%	+$42.8K	﹤0.01%	2049
2024 Q2	$652K	Buy	+22,778	New	+$648K	﹤0.01%	1692

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PCRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Pacira BioSciences (PCRX) stake by 4.8% in Q2 2026, selling an estimated $21.8K and leaving 18,265 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Mirae Asset Global ETFs Holdings first reported a position in PCRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $677K in Q1 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 18,265 shares of Pacira BioSciences worth $463K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 923 Pacira BioSciences shares in Q2 2026, an estimated $21.8K.
Pacira BioSciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2051 holding.
Mirae Asset Global ETFs Holdings first reported a position in Pacira BioSciences in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Pacira BioSciences position peaked at $677K in Q1 2025.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.